|
Quotes & Info
|
| OPXA > SEC Filings for OPXA > Form 8-K on 5-Nov-2009 | All Recent SEC Filings |
5-Nov-2009
Other Events, Financial Statements and Exhibits
On November 5, 2009, Opexa Therapeutics, Inc. (the "Company") issued a press release announcing that Neil K. Warma, the Company's president and chief executive officer, will deliver a corporate presentation at the Merriman Curhan Ford 6th Annual Investor Summit 2009. The Company's presentation will take place at 4:40 p.m. (EST) on Tuesday, November 10, 2009 at the Sofitel New York Hotel in New York City. The presentation will include an overview of the company's ongoing clinical development program for Tovaxin®, the company's lead therapy for multiple sclerosis. The presentation will be webcasted and the link to access the audio webcast and presentation will be available at www.opexatherapeutics.com.
(c) Exhibit 99.1
The following exhibit is to be filed as part of this 8-K:
Exhibit No. Description
99.1 Press release issued November 5, 2009 relating to presentation at the
Merriman Curhan Ford 6th Annual Investor Summit 2009
|
|